PHARMA ALLY
Honeywell to acquire industrial cyber security software leader Nextnine Broadens industrial cyber security offerings to meet increasing threat to industrial facilities and critical infrastructure HONEYWELL SIGNED a definitive agreement to purchase Nextnine, a privately held provider of security management solutions and technologies for industrial cyber security. The addition of Nextnine’s industry-leading security solutions and secure remote service capabilities will enhance the company’s existing range of innovative cyber security technologies and significantly increase Honeywell’s Connected Plant cyber security customer base. Nextnine’s flagship technology, ICS Shield, protects industrial sites from cyber security attacks and enables remote monitoring of assets. It complements Honeywell’s extensive cyber security portfolio with a solution that is used at more than 6,200 sites glob-
ally across the oil and gas, utility, chemical, mining and manufacturing sectors. Previously, ICS Shield had to be deployed separately for each control system vendor, resulting in multiple and separate installations at a single customer site. With this acquisition, customers will be able to deploy and operate a single system, thereby simplifying and better securing their entire site with Honeywell’s proven capability to provide multi-vendor solutions. Founded in 1998, Nextnine has been backed to date by Infinity VC, XT Hi-Tech and several other prominent investors. “Each day, the number of attempted cyber-attacks on industrial facilities and critical infrastructure around the world increases,” said Vimal Kapur, President, Honeywell
Process Solutions. “This acquisition shows our ongoing commitment to providing our customers with a comprehensive portfolio of cyber security solutions to protect and defend their industrial control systems and process control networks. Honeywell’s extensive global reach will increase Nextnine’s availability to a broader range of customers.” Nextnine’s security solutions also will be a key enabler of Honeywell Connected Plant, which combines Honeywell’s unmatched industrial expertise, software and digital technologies to make its customers’ operations more reliable, profitable and secure than ever before possible. Cyber security is a critical part of that programme. EP News Bureau
5th edition of India Chem Gujarat 2017 to be held in Gandhinagar The event to be held from September 21-22, 2017, aims to showcase the potential of the Indian chemicals sector and allied industry A CURTAIN raiser of ‘India Chem Gujarat 2017’, the 5th edition of the international exhibition and conference of the chemicals industry in India was presided over by Mansukh L Mandaviya, Minister of State for Road Transport & Highways, Shipping, Chemical & Fertilizers, Govt of India, in Mumbai in the presence of Samir Kumar Biswas, Joint Secretary, Chemicals, Dept of Chemicals & Petrochemicals, Ministry of Chemicals & Fertilizers, Govt of India. The biennial event, will be jointly organised by the Federation of Indian Chambers of Commerce and Industry (FICCI), Department of Chemicals and Fertilizers, Govt of India, Govt of Gujarat, and iNDEXTb. While speaking at the curtain raiser Mandaviya said, “Mandaviya added, “Make in India initiative will provide necessary support to companies for investment in the sector which is likely
to grow by 9 per cent p.a. to reach $226 billion by 2020.” With structured buyer-seller meet, 150 exhibitors and more than 7000 business visitors are expected to make their presence at the event. The endeavour is to bring out winning strategies for building and strengthening the awareness of emerging new application of specialty chemicals sector and allied industry and highlight the application technologies to enhance productivity. The event will witness the presence of industry CEOs, engineers, technocrats and scientists; marketing heads, purchase heads, professionals and consultants; policy makers and foreign commercials corps; head R&D, regulatory affairs and quality managers; industry associations and international trade delegations; manufactures, entrepreneurs, owners, end users etc. EP News Bureau
CONTRIBUTOR’S CHECKLIST ❒ Express Pharma accepts editorial material for
❒ We welcome information on new products and
regular columns and from pre-approved contributors / columnists. ❒ Express Pharma has a strict non-tolerance policy of plagiarism and will blacklist all authors found to have used/refered to previously published material in any form, without giving due credit in the industryaccepted format. All authors have to declare that the article/column is an original piece of work and if not, they will bear the onus of taking permission for re-publishing in Express Pharma. ❒ Express Pharma's prime audience is senior management and pharma professionals in the industry. Editorial material addressing this audience would be given preference. ❒ The articles should cover technology and policy trends and business related discussions. ❒ Articles for columns should talk about concepts or trends without being too company or product specific. ❒ Article length for regular columns: Between 1200 1500 words. These should be accompanied by diagrams, illustrations, tables and photographs, wherever relevant.
services introduced by your organisation for our various sections: Pharma Ally (News, Products, Value Add), Pharma Packaging and Pharma Technology Review sections. Related photographs and brochures must accompany the information. ❒ Besides the regular columns, each issue will have a special focus on a specific topic of relevance to the Indian market. ❒ In e-mail communications, avoid large document attachments (above 1MB) as far as possible. ❒ Articles may be edited for brevity, style, and relevance. ❒ Do specify name, designation, company name, department and e-mail address for feedback, in the article. ❒ We encourage authors to send their photograph. Preferably in colour, postcard size and with a good contrast.
56 EXPRESS PHARMA July 1-15, 2017
Email your contribution to: The Editor, Express Pharma, Business Publications Division,
The Indian Express (P) Ltd, 1st Floor, Express Towers, Nariman Point, Mumbai - 400 021. Tel: 91-22-2202 2627 / 2285 1964/ 6744 0000 Fax: 91-22-2288 5831 viveka.r@expressindia.com